# SARCLISA ESCENA
> **BLA761445** · Biologics License Application · Sponsor: SANOFI-AVENTIS U.S. LLC · Approved 2026-07-09
## Drug
- **FDA Application Number:** BLA761445
- **Application type:** Biologics License Application
- **Brand name:** SARCLISA ESCENA
- **Generic name:** ISATUXIMAB-IRFC
- **Active ingredients:** ISATUXIMAB-IRFC
- **Dosage form:** VIAL
- **Route:** SINGLE-DOSE
- **Marketing status:** Prescription
- **Sponsor:** SANOFI-AVENTIS U.S. LLC
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 2026-07-09
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761445)
---
*MORVS · CC0 1.0*